IP Library › Granted Patent US 9,717,751
Granted Patent B2
US 9,717,751 · App. 14/648,919 · Granted Aug 1, 2017

Chitin or derivatives thereof for the prevention and/or treatment of parasitoses

Inventors: Eric Auclair (Aveline, FR); Jean-Philippe Marden (Labege, FR); Fabrice Laurent (Rochecorbon, FR); Sonia Lacroix-Lamande (Bueil en Tourain, FR)
Assignee: LESAFFRE ET COMPAGNIE
A61K31/722A61K31/7008A61K33/04A61K33/44A61K35/742A61K35/747A61K36/064A61K36/53A61K36/54A61K36/899A61K36/8962A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,717,751
App. No.
14/648,919
Granted
Aug 1, 2017
Kind
B2
Abstract

The subject matter of the present invention is the use of chitin or a derivative of chitin for preventing and/or treating parasitoses, and in particular cryptosporidiosis. The present invention also pertains to a composition that comprises at least one base agent chosen from among chitin or a derivative of chitin and at least one secondary agent chosen from among an agent for stimulating immunity and an antiparasite agent, as well as the use of same for preventing and/or treating parasitoses, in particular cryptosporidiosis.

Claims (7)

1. A method for treating cryptosporidiosis comprising administering to humans or animals infected with Cryptosporidium a composition comprising a base agent and an agent for stimulating immunity, wherein

the base agent is chosen from chitin or a chitin derivative comprising chitosan, N-acetylglucosamine or glucosamine, and

the agent for stimulating immunity is chosen from a yeast cell wall, a yeast extract, selenium, a bacterium of the Bacillus, Lactobacillus, Bifidobacterium, Enterococcus, Propionibacterium, Pediococcus or Lactococcus genus, a yeast of the Saccharomyces or Kluyveromyces genus, or a combination thereof.

2. The method as claimed in claim 1 , wherein the composition also comprises an antiparasitic agent chosen from an essential oil, active carbon, lauric acid, or combinations thereof.

3. The method as claimed in claim 2 , wherein the essential oil is chosen from garlic essential oil, citronella essential oil, cinnamon essential oil, thyme essential oil, oregano essential oil, tea tree essential oil, lemon essential oil, eucalyptus essential oil, or combinations thereof.

4. The method as claimed in claim 1 , wherein the selenium is in the form of a selenium-enriched yeast, selenium totally or partially extracted from yeast, or combinations thereof.

5. The method as claimed in claim 1 , wherein the composition is a food composition, a food supplement or a pharmaceutical composition.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2015
From: AUCLAIR, ERIC; MARDEN, JEAN-PHILIPPE; LAURENT, FABRICE; LACROIX-LAMANDE, SONIA
To: LESAFFRE ET COMPAGNIE
Reel/Frame 036081/0295 →
Priority Claims (1)
FR 12 62072 · Dec 14, 2012 · national
Continuity (1)
Related Publication 20150297632A1 · Oct 22, 2015